Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial-stage development company that offers non-invasive medical devices. The company’s products include Electroceutical, palliative treatment of pain and post-surgical edema and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Its Electroceutical Therapy indications are chronic wounds. Endonovo Therapeutics’ pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders which include acute concussions, post-concussion syndrome, ischemic heart disease, traumatic brain injury and multiple sclerosis. The company’s Electroceuticals are electronic devices designed to affect biological systems to alleviate or mitigate symptomatology and pathology. Endonovo Therapeutics is headquartered in Woodland Hills, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Endonovo Therapeutics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Endonovo Therapeutics Inc Company Overview
- Endonovo Therapeutics Inc Company Snapshot
- Endonovo Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Endonovo Therapeutics Inc - Pipeline Analysis Overview
- Endonovo Therapeutics Inc - Key Facts
- Endonovo Therapeutics Inc - Major Products and Services
- Endonovo Therapeutics Inc Pipeline Products by Development Stage
- Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status
- Endonovo Therapeutics Inc Pipeline Products Overview
- Bioelectronic Device - Acute Myocardial Infarction
- Bioelectronic Device - Acute Myocardial Infarction Product Overview
- Bioelectronic Device - Chronic Kidney Disease
- Bioelectronic Device - Chronic Kidney Disease Product Overview
- Bioelectronic Device - Fulminant Liver Failure
- Bioelectronic Device - Fulminant Liver Failure Product Overview
- Bioelectronic Device - Urinary Incontinence
- Bioelectronic Device - Urinary Incontinence Product Overview
- DSF-rTMS
- DSF-rTMS Product Overview
- Multi-Coil Transcranial Magnetic Stimulation System
- Multi-Coil Transcranial Magnetic Stimulation System Product Overview
- Non-Invasive Electroceutical Device - CKD
- Non-Invasive Electroceutical Device - CKD Product Overview
- Non-Invasive Electroceutical Device - CLI
- Non-Invasive Electroceutical Device - CLI Product Overview
- Non-Invasive Electroceutical Device - NASH
- Non-Invasive Electroceutical Device - NASH Product Overview
- Protex Brace And Hook
- Protex Brace And Hook Product Overview
- SofPulse
- SofPulse Product Overview
- SofPulse Clinical Trial
- SofPulse - COVID-19
- SofPulse - COVID-19 Product Overview
- Endonovo Therapeutics Inc - Key Competitors
- Endonovo Therapeutics Inc - Key Employees
- Endonovo Therapeutics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Endonovo Therapeutics Inc, Recent Developments
- Jun 07, 2023: Endonovo Pending Agreement to Develop Telehealth Division
- Mar 01, 2022: Endonovo Therapeutics Appoints Garry Michael Kann As Head of Corporate Development To Identify And Acquire Profitable Companies For Endonovo
- Mar 02, 2020: Endonovo Therapeutics files 8K with SEC regarding SofPulse
- Feb 24, 2020: Endonovo Therapeutics introduces support of SofPulse with a new ancillary multi-use patient brace from Protex
- Feb 20, 2020: Endonovo Therapeutics begins process for medical reimbursements
- Feb 13, 2020: Endonovo Therapeutics announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study
- Feb 10, 2020: Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse for Orthopedic Surgeries
- Jan 30, 2020: Endonovo Therapeutics expands SofPulse sales to plastic surgery centers
- Jan 27, 2020: Endonovo Therapeutics announces first SofPulse sales to a Veterans Medical Center
- Jan 14, 2020: Endonovo Therapeutics announces issuance of broad patent covering electromagnetic treatment of multiple sclerosis
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Endonovo Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Endonovo Therapeutics Inc Pipeline Products by Equipment Type
- Endonovo Therapeutics Inc Pipeline Products by Indication
- Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status
- Endonovo Therapeutics Inc, Key Facts
- Endonovo Therapeutics Inc, Major Products and Services
- Endonovo Therapeutics Inc Number of Pipeline Products by Development Stage
- Endonovo Therapeutics Inc Pipeline Products Summary by Development Stage
- Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status
- Endonovo Therapeutics Inc Ongoing Clinical Trials Summary
- Bioelectronic Device - Acute Myocardial Infarction - Product Status
- Bioelectronic Device - Acute Myocardial Infarction - Product Description
- Bioelectronic Device - Chronic Kidney Disease - Product Status
- Bioelectronic Device - Chronic Kidney Disease - Product Description
- Bioelectronic Device - Fulminant Liver Failure - Product Status
- Bioelectronic Device - Fulminant Liver Failure - Product Description
- Bioelectronic Device - Urinary Incontinence - Product Status
- Bioelectronic Device - Urinary Incontinence - Product Description
- DSF-rTMS - Product Status
- DSF-rTMS - Product Description
- Multi-Coil Transcranial Magnetic Stimulation System - Product Status
- Multi-Coil Transcranial Magnetic Stimulation System - Product Description
- Non-Invasive Electroceutical Device - CKD - Product Status
- Non-Invasive Electroceutical Device - CKD - Product Description
- Non-Invasive Electroceutical Device - CLI - Product Status
- Non-Invasive Electroceutical Device - CLI - Product Description
- Non-Invasive Electroceutical Device - NASH - Product Status
- Non-Invasive Electroceutical Device - NASH - Product Description
- Protex Brace And Hook - Product Status
- Protex Brace And Hook - Product Description
- SofPulse - Product Status
- SofPulse - Product Description
- SofPulse - A Pilot Prospective, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy in Decreasing Post-operative Pain Following Orthopedic Surgery
- SofPulse - COVID-19 - Product Status
- SofPulse - COVID-19 - Product Description
- Endonovo Therapeutics Inc, Key Employees
- Glossary
- Endonovo Therapeutics Inc Pipeline Products by Equipment Type
- Endonovo Therapeutics Inc Pipeline Products by Development Stage
- Endonovo Therapeutics Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Biotherapeutics Inc
- Galera Therapeutics Inc
- Lundbeck La Jolla Research Center Inc
- Abeona Therapeutics Inc
- 4D Molecular Therapeutics Inc
- Lundbeck La Jolla Research Center Inc
- AbbVie Biotherapeutics Inc
- Galera Therapeutics Inc
- 4D Molecular Therapeutics Inc
- Abeona Therapeutics Inc
